Aakaar Medical Technologies IPO: Price, Overview, And GMP

Aakaar Medical Technologies IPO- Complete Overview

Aakaar Medical Technologies IPO under the SME IPO category is a book build issue of Rs. 27 Cr by Aakaar Medical Technologies Limited. The company was established in 2013 and is an aesthetic medical company, with a wide range of specialised products & devices.

The company specializes in products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists. It has its brands, and also imports a variety of equipment from South Korea, Spain, Italy, and Austria.

The company sells products and devices primarily to dermatologists, plastic surgeons, and aesthetic physicians who resell them to end consumers as well as use some consumables in treatments. 

Product Portfolio

• This includes home care and professional skin care benefits.

• Fillers and shaping, Homecare for the skin, Pro Hair Care.

• DermaSet Professional Skincare products.

• Hair Growth Serum & Tablets.

• Hair Serum, Anti-hair loss solution.

• Medifacial Kit.

• Device for the incontinence of urine.

• Devices used for tattoo removal, pigmentation, and skin rejuvenation.

• Laser Hair Reduction devices.

• Hair Transplant Device.

 

Aakaar Medical Technologies IPO Overview

The Aakaar Medical Technologies IPO date is on 20 June 2025, and its initial public offering will end on 24 June 2025. 

The Rs. 27 crore new SME IPO comprises a wholly fresh issue of 37.50 lac Shares. This upcoming IPO is available for subscription from June 20 to June 24, 2025. Aakaar Medical Technologies IPO price is Rs. 68 to Rs. 72 for each Share. 

The expected Aakaar Medical Technologies IPO listing date is Friday, Jun 27, 2025, and listing at the NSE and SME.

Click to open demat account and apply for the IPO.

Company Financial

(Amount in Lac)

 

Revenue Bifurcation

Product Segment-wise Revenue Bifurcation

 

Business Model-wise Revenue Bifurcation

(Source: RHP) 

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Financing the company's operating cash needs.

• General corporate purposes.
  
  

Click to check the IPO application status.

Peers of Aakaar Medical Technologies Ltd.

No listed peer of the comparable size and similar nature exists for this company, as mentioned in the RHP.

Evaluation

The Aakaar Medical Technologies Limited IPO price is Rs. 68 to Rs. 72 for each Share.

 

 

Evaluation of P/E Ratio

Considering the FY ended 31 Mar 2025 with an EPS of Rs. 6.13 from the last year, the resulting P/E ratio is 11.74x.

Considering the weighted EPS of Rs. 4.51 for the last three years, the P/E ratio is 15.96x.

Explore Influx Healthtech IPO.

 

IPO's Strengths

• Professional management & leadership team.

• Differentiated large customer base.

• Differences across the product base.

• Pan India distribution network of our consignment sales partner.

 

IPO’s Weaknesses

• The company makes most of its money importing third-party brands from countries like Korea, Spain, Italy, and Austria to sell online. That exposes the company to a host of risks, from supply chain to shifts in imports, new tariffs, or geopolitical risk that might disrupt operations, profitability, or inventory cushion.

• It does not have its own manufacturing facilities and outsources all its products to third parties. Variations in the cost of raw materials, utilities, transportation, or inefficiencies from such independent facilities can adversely affect the cost of products, margins, and business continuity.

• The Company's reliance on domestic and international third-party manufacturers subjects it to risks, including supply disruptions, the potential bankruptcy of manufacturers, infringement of trade secrets and quality control, any of which could adversely affect its business and financial condition. 

 

Aakaar Medical Technologies IPO GMP

Aakaar Medical Technologies IPO GMP is Rs. 0 as of 17 Jun 2025 while writing this information. Hence, its estimated listing price is Rs. 72.

IPO Timetable (Tentative)

The Aakaar IPO date of opening is from Jun 20 to Jun 24, 2025, allotment on Jun 25, refund initiation on Jun 26, and listing on Jun 27, 2025.

Events	Date
IPO Opening Date	Jun 20, 2025
IPO Closing Date	Jun 24, 2025
IPO Allotment Date	Jun 25, 2025
Refund Initiation	Jun 26, 2025
IPO Listing Date	Jun 27, 2025

 

Aakaar Medical Technologies IPO Details 

The IPO with a Face Value of Rs. 10 per share offers a total issue size of 37,50,400 Shares (Rs. 27 Cr).

IPO Opening & Closing Date	20 Jun, 2025 to 24 Jun, 2025
Face Value	Rs. 10 per Share
Issue Price	Rs. 68 to Rs. 72 per Share.
Lot Size	1600 Shares
Issue Size	37,50,400 Shares (Rs. 27 Cr)
Offer for Sale	-
Fresh Issue	37,50,400 Shares (Rs. 27 Cr)
Listing at	NSE, SME
Issue Type	Book building Issue
Registrar	Bigshare Services Pvt Ltd.

 

 

IPO Lot Details 

The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (1600 Shares) amounting to Rs. 1,15,200 and in multiples thereof, while for HNI investors, the minimum Lot is 2 (3200 Shares) amounting to Rs. 2,30,400.

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	1 Lot
HNI (Min)	2 Lots

 

IPO Reservation (% of Net Issue)

Institutional’s Portion	50%
Retail’s Portion	35%
Non-Institutional’s Portion	15%

 

Promoters And Management of Aakaar Medical Technologies Ltd.

• Dilip Ramesh Meswani.

• Bindi Dilip Meswani.

Pre-Issue Promoter Shareholding	91.11%
Post-Issue Promoter Shareholding	-

 

IPO Lead Managers

• Indorient Financial Services Ltd.

 

 

Dividend Policy

The company has paid a dividend of Rs. 7.5 having a rate of dividend of 75% as of 31 March 2023.

 

Conclusion

Investors get a chance to partake in the Indian aesthetic medical devices industry with Aakaar Medical Technologies' IPO. The company has a strong professional management team, a wide range of product offerings, and a pan-India distribution network. But depending on imports and third-party makers is a vulnerability. These factors need to be considered by investors before investing in this SME IPO. 

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is for educational and information purposes only. Always discuss with your eligible financial advisor for investment-related decisions. 

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.